Linda B. Tabas
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 12
-
- Pharmacological Effects and Toxicity Studies 4
- Biochemistry top 10%
- Amino Acid Enzymes and Metabolism 3
- Psychiatry and Mental health top 10%
- Dementia and Cognitive Impairment Research 3
- Pharmaceutical Science top 10%
-
- Pediatric Hepatobiliary Diseases and Treatments 3
-
- Adenosine and Purinergic Signaling 2
-
- Epigenetics and DNA Methylation 2
-
- Antibiotics Pharmacokinetics and Efficacy 2
- Co-authors
- Anne H. DantzigRobert L. ShepardDale C. DuckworthJames J. StarlingPaula T. TrzepaczSusan E. PrattTammy ForresterBrian A. Willis
- Journals
- Science (1 paper)Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Linda B. Tabas
17 papers receiving 885 citations
Peers
Comparison fields: 5 of 93
- Oncology 499
- Pediatrics, Perinatology and Child Health 217
- Biochemistry 73
- Psychiatry and Mental health 147
- Pharmaceutical Science 47
Countries citing papers authored by Linda B. Tabas
This map shows the geographic impact of Linda B. Tabas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda B. Tabas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda B. Tabas more than expected).
Fields of papers citing papers by Linda B. Tabas
This network shows the impact of papers produced by Linda B. Tabas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda B. Tabas. The network helps show where Linda B. Tabas may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Linda B. Tabas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2015 | 35 | |
| 3 | 2012 | 43 | |
| 4 | 2012 | 107 | |
| 5 | 2009 | 23 | |
| 6 | 2005 | 49 | |
| 7 | Cloning and functional characterization of the multidrug resistance-associated protein (MRP1/ABCC1) from the cynomolgus monkey. | 2003 | 18 |
| 8 | 2003 | 31 | |
| 9 | 2002 | 50 | |
| 10 | 2002 | 25 | |
| 11 | 2002 | 55 | |
| 12 | 1999 | 23 | |
| 13 | 1999 | 149 | |
| 14 | 1997 | 35 | |
| 15 | 1994 | 56 | |
| 16 | 1994 | 153 | |
| 17 | 1992 | 57 |
About Linda B. Tabas
Linda B. Tabas is a scholar working on Physiology, Oncology and Biochemistry, having authored 17 papers that have together received 911 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (12 papers), Pharmacological Effects and Toxicity Studies (4 papers), Amino Acid Enzymes and Metabolism (3 papers), Dementia and Cognitive Impairment Research (3 papers), Pediatric Hepatobiliary Diseases and Treatments (3 papers), Adenosine and Purinergic Signaling (2 papers), Epigenetics and DNA Methylation (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). The work is most often cited by research in Oncology (499 citations), Pediatrics, Perinatology and Child Health (217 citations) and Biochemistry (73 citations). Linda B. Tabas has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Anne H. Dantzig, Robert L. Shepard, Dale C. Duckworth, James J. Starling, Paula T. Trzepacz, Susan E. Pratt, Tammy Forrester, Brian A. Willis, Steven Wrighton and Jennifer S. Gillespie. Their work appears in journals such as Science, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.